These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
853 related articles for article (PubMed ID: 33939733)
1. Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis. Li X; Zhong X; Wang Y; Zeng X; Luo T; Liu Q PLoS One; 2021; 16(5):e0250602. PubMed ID: 33939733 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors. Yin T; Li Y; Ying Y; Luo Z BMC Infect Dis; 2021 Feb; 21(1):200. PubMed ID: 33618678 [TBL] [Abstract][Full Text] [Related]
3. Predictors of adverse prognosis in COVID-19: A systematic review and meta-analysis. Figliozzi S; Masci PG; Ahmadi N; Tondi L; Koutli E; Aimo A; Stamatelopoulos K; Dimopoulos MA; Caforio ALP; Georgiopoulos G Eur J Clin Invest; 2020 Oct; 50(10):e13362. PubMed ID: 32726868 [TBL] [Abstract][Full Text] [Related]
4. The anatomy of COVID-19 comorbidity networks among hospitalized Korean patients. Shin EK; Choi HY; Hayes N Epidemiol Health; 2021; 43():e2021035. PubMed ID: 33971700 [TBL] [Abstract][Full Text] [Related]
5. Prevalence and predictors of death and severe disease in patients hospitalized due to COVID-19: A comprehensive systematic review and meta-analysis of 77 studies and 38,000 patients. Dorjee K; Kim H; Bonomo E; Dolma R PLoS One; 2020; 15(12):e0243191. PubMed ID: 33284825 [TBL] [Abstract][Full Text] [Related]
6. Features of severe COVID-19: A systematic review and meta-analysis. Del Sole F; Farcomeni A; Loffredo L; Carnevale R; Menichelli D; Vicario T; Pignatelli P; Pastori D Eur J Clin Invest; 2020 Oct; 50(10):e13378. PubMed ID: 32860457 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature. Bajgain KT; Badal S; Bajgain BB; Santana MJ Am J Infect Control; 2021 Feb; 49(2):238-246. PubMed ID: 32659414 [TBL] [Abstract][Full Text] [Related]
8. Meta-analysis investigating the relationship between clinical features, outcomes, and severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia. Li J; He X; Yuan Yuan ; Zhang W; Li X; Zhang Y; Li S; Guan C; Gao Z; Dong G Am J Infect Control; 2021 Jan; 49(1):82-89. PubMed ID: 32540370 [TBL] [Abstract][Full Text] [Related]
9. Association between chronic kidney disease and COVID-19-related mortality in New York. Mohamed NE; Benn EKT; Astha V; Okhawere KE; Korn TG; Nkemdirim W; Rambhia A; Ige OA; Funchess H; Mihalopoulos M; Meilika KN; Kyprianou N; Badani KK World J Urol; 2021 Aug; 39(8):2987-2993. PubMed ID: 33481113 [TBL] [Abstract][Full Text] [Related]
10. The Involvement of Chronic Kidney Disease and Acute Kidney Injury in Disease Severity and Mortality in Patients with COVID-19: A Meta-Analysis. Wang B; Luo Q; Zhang W; Yu S; Cheng X; Wang L; Chen X; Chen Y Kidney Blood Press Res; 2021; 46(1):17-30. PubMed ID: 33352576 [TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and outcomes of patients with Corona Virus Disease 2019 (COVID-19) at Mercy Health Hospitals, Toledo, Ohio. Khan MS; Dogra R; Miriyala LKV; Salman FNU; Ishtiaq R; Patti DK; Kumar A; Sandho G; Jacob K; Luthra K; Sharma R; Ravikumar R; Edara D; Pittampalli S; Sood D; Khatri V; Mahajan V; Avasthi S; Auoad A; Katragadda S PLoS One; 2021; 16(4):e0250400. PubMed ID: 33886663 [TBL] [Abstract][Full Text] [Related]
12. The Clinical Characteristics and Risk Factors of Severe COVID-19. Hu J; Wang Y Gerontology; 2021; 67(3):255-266. PubMed ID: 33406518 [TBL] [Abstract][Full Text] [Related]
13. Eosinophilia in Asthma Patients Is Protective Against Severe COVID-19 Illness. Ferastraoaru D; Hudes G; Jerschow E; Jariwala S; Karagic M; de Vos G; Rosenstreich D; Ramesh M J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1152-1162.e3. PubMed ID: 33495097 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of co-morbidities and their association with mortality in patients with COVID-19: A systematic review and meta-analysis. Singh AK; Gillies CL; Singh R; Singh A; Chudasama Y; Coles B; Seidu S; Zaccardi F; Davies MJ; Khunti K Diabetes Obes Metab; 2020 Oct; 22(10):1915-1924. PubMed ID: 32573903 [TBL] [Abstract][Full Text] [Related]
15. Chronic comorbidities and clinical outcomes in patients with and without COVID-19: a large population-based study using national administrative healthcare open data of Mexico. Martos-Benítez FD; Soler-Morejón CD; García-Del Barco D Intern Emerg Med; 2021 Sep; 16(6):1507-1517. PubMed ID: 33411264 [TBL] [Abstract][Full Text] [Related]
16. Risk factors for the exacerbation of patients with 2019 Novel Coronavirus: A meta-analysis. Zhao J; Li X; Gao Y; Huang W Int J Med Sci; 2020; 17(12):1744-1750. PubMed ID: 32714077 [TBL] [Abstract][Full Text] [Related]
17. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients. Dessie ZG; Zewotir T BMC Infect Dis; 2021 Aug; 21(1):855. PubMed ID: 34418980 [TBL] [Abstract][Full Text] [Related]
18. Impact and prevalence of comorbidities and complications on the severity of COVID-19 in association with age, gender, obesity, and pre-existing smoking: A meta-analysis. Djorwé S; Bousfiha A; Nzoyikorera N; Nyandwi J; Kawthar B; Malki A Biomedicine (Taipei); 2024; 14(1):20-38. PubMed ID: 38533301 [TBL] [Abstract][Full Text] [Related]
19. Epidemiological, comorbidity factors with severity and prognosis of COVID-19: a systematic review and meta-analysis. Fang X; Li S; Yu H; Wang P; Zhang Y; Chen Z; Li Y; Cheng L; Li W; Jia H; Ma X Aging (Albany NY); 2020 Jul; 12(13):12493-12503. PubMed ID: 32658868 [TBL] [Abstract][Full Text] [Related]
20. Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events. Nandy K; Salunke A; Pathak SK; Pandey A; Doctor C; Puj K; Sharma M; Jain A; Warikoo V Diabetes Metab Syndr; 2020; 14(5):1017-1025. PubMed ID: 32634716 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]